Stock Events

Stock Events

Pulmonx 

$1.33
8
+$0.05+3.91% Thursday 20:00

Statistics

Day High
1.34
Day Low
1.24
52W High
7.03
52W Low
1.13
Volume
176,397
Avg. Volume
509,283
Mkt Cap
54.86M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.45
-0.38
-0.32
-0.25
Expected EPS
-0.326667
Actual EPS
N/A

Financials

-67.3%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
167.58MRevenue
-112.79MNet Income

Analyst Ratings

$7.67Average Price Target
The highest estimate is 14.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LUNG. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
B2gold
BTG
Mkt Cap5.81B
BTG International's interventional pulmonology portfolio, including devices for lung volume reduction, competes directly with Pulmonx's Zephyr Valves.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers a range of respiratory and monitoring solutions that can compete with Pulmonx's diagnostic and therapeutic technologies.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation provides various interventional pulmonology solutions, including airway stents and devices for lung cancer diagnosis and treatment, competing with Pulmonx's offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its Ethicon subsidiary, offers products for thoracic surgery and lung health, potentially competing with Pulmonx's lung function improvement solutions.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Philips offers a wide range of respiratory care solutions, including sleep and respiratory care devices, which can indirectly compete with Pulmonx's products.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew, with its advanced surgical devices, can compete in the space of lung and thoracic surgery, offering alternatives to Pulmonx's solutions.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical's da Vinci robotic surgical systems are used in thoracic procedures, offering a high-tech alternative to traditional and minimally invasive lung surgeries.
Hologic
HOLX
Mkt Cap16.45B
Hologic's imaging and interventional solutions, including those for lung and thoracic applications, offer diagnostic alternatives that can compete with Pulmonx's lung health diagnostics.

About

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Show more...
CEO
Mr. Glendon E. French
Employees
291
Country
US
ISIN
US7458481014

Listings

F
DE
4NI.F
XNAS
US
LUNG
BOATS
BOATS
LUNG.BOATS

0 Comments

Share your thoughts

FAQ

What is Pulmonx stock price today?▼
The current price of LUNG is $1.33 USD — it has increased by +3.91% in the past 24 hours. Watch Pulmonx stock price performance more closely on the chart.
What is Pulmonx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pulmonx stocks are traded under the ticker LUNG.
Is Pulmonx stock price growing?▼
LUNG stock has risen by +13.68% compared to the previous week, the month change is a -7.64% fall, over the last year Pulmonx has showed a -80.33% decrease.
What is Pulmonx market cap?▼
Today Pulmonx has the market capitalization of 54.86M
When is the next Pulmonx earnings date?▼
Pulmonx is going to release the next earnings report on May 05, 2026.
What were Pulmonx earnings last quarter?▼
LUNG earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.39 USD resulting in a +35.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pulmonx revenue for the last year?▼
Pulmonx revenue for the last year amounts to 167.58M USD.
What is Pulmonx net income for the last year?▼
LUNG net income for the last year is -112.79M USD.
How many employees does Pulmonx have?▼
As of April 04, 2026, the company has 291 employees.
In which sector is Pulmonx located?▼
Pulmonx operates in the Health Care sector.
When did Pulmonx complete a stock split?▼
Pulmonx has not had any recent stock splits.
Where is Pulmonx headquartered?▼
Pulmonx is headquartered in Redwood City, US.